Local Recurrence of Primary Cardiac Leiomyosarcoma After Resection: A Rare Case

Fatih TAY, Mustafa Büyükkör, Öztürk Ateş


Introduction: Leiomyosarcoma (LMS) is a fatal tumor, though primary cardiac is very rarely encountered. In this report, we evaluated the surgical and medical management of primary cardiac LMS, which is a sporadic tumor.

Case Presentation: A 60-year-old female patient was examined for pulmonary edema after penicillin allergy in May 2019, while transthoracic echocardiography (ECHO) revealed an appearance compatible with a 5x3.5 cm mass in the right atrium. In addition, transesophageal ECHO showed a 7x4.6 cm foreground mass compatible with a myxoma in the right atrium (RA). The patient was then operated on emergency. Besides, an adjuvant ifosfamide-mesna-doxorubicine (IMA) protocol was planned to be given to the patient after local radiotherapy.

Conclusions: In this report presented, we made RT and chemotherapy treatment plans in the case of recurrence without R0 surgery. Recurrence rates of up to 50% can occur in LMS, and systemic chemotherapy can be applied after relapse


cardiac leiomyosarcoma, cardiac tumors, soft tissue sarcomas


Maleszewski JJ, Bois MC, Bois JP, et al. Neoplasia and the heart: A pathological review of effects with clinical and radiological correlation. J Am Coll Cardiol. 2018;72(2):202‐27.

Kosuga T, Fukunaga S, Kawara T, et al. Surgery for primary cardiac tumors. Clinical experience and surgical results in 60 patients. J Cardiovasc Surg (Torino). 2002;43(5):581-7.

McAllister HA Jr. Cardiovascular pathology. Churchill Livingstone, New York, 1983.

Weir DR, Joncs BC Jr, Ohio C. Primary sarcoma of the heart. Am Heart J. 1940;22:556-60.

Poole GV Jr, Meredith JW, Breyer RH, Mills SA. Surgical implications in malignant cardiac disease. Ann Thorac Surg. 1983;36:484-91.

Pins MR, Ferrell MA, Madsen JC, et al. Epithelioid and spindle-celled leiomyosarcoma of the heart: Report of 2 cases and review of the literature. Arch Pathol Lab Med. 1999;123(9):782-8.

Antman K, Crowley J, Balcerzak SP, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 1993;11(7):1276-85.

Truong PT, Jones SO, Martens B, et al. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience. Ann Surg Oncol. 2009;16(12):3358-65.

Full Text: PDF

DOI: 10.33371/ijoc.v15i4.833

Article Metrics

Abstract view : 28 times
PDF - 17 times


  • There are currently no refbacks.

Copyright (c) 2021 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.